CAS No. 13951-70-7 | 11a,16b,17,21-Tetrahydroxy-pregna-1,4-diene-3,20-dione
Name: 11a,16b,17,21-Tetrahydroxy-pregna-1,4-diene-3,20-dione CAS No.13951-70-7 MF:C21H28O6 MW:376.44 Purity:98% Package: 5g,25g,200g,500g,1kg Worldwide Delivery
Categories:
Other Life Science Chemicals
Email:sale06@alfachem.cn
Product introduction
Introduction and application of CAS No. 13951-70-7 | 11a,16b,17,21-Tetrahydroxy-pregna-1,4-diene-3,20-dione
Synonyms:16A-HYDROXY-PREDNISONLONE;
11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione;
16AlphaHydroxprednisolone;
16α-HYDROXY-PREDNISONLONE;
11,16a,17a,21-Tetrahydroxypregna-1,4-diene-3,20-dione;
16A-HYDROXY-PREDNISOLONE;
11a,16b,17,21-tetrahydroxy-pregna-1,4-diene-3,20-dione
Specification:
|
ITEMS |
SPECIFICATION |
|
CAS |
13951-70-7 |
|
MF |
C21H28O6 |
|
MW |
376.44 |
|
Melting point |
235-238°C |
|
Boiling point |
591.5±50.0 °C |
|
Density |
1.38±0.1 g/cm3 |
|
Acidity coefficient |
11.93±0.70 |
|
Color |
White to light yellow to light orange |
|
Solubility |
Soluble in DMSO (slightly), methanol (slightly, heating) |
|
Form |
Solid |
|
Storage condition |
Sealed in dry,2-8°C |
Overview:
16a-Hydroxyprednisolone, a glucocorticoid API intermediate, is an intermediate for the synthesis of acetonide drugs that have been approved for marketing, including triamcinolone acetonide, budesonide, ciclesonide and desonide. Nedide drugs are inhaled glucocorticoids with the characteristics of local application, low dosage, strong local anti-inflammatory effect, and few systemic side effects. They are widely used in the treatment of refractory asthma and inflammation.
Package and transportation :
Package: 5g,25g,200g,500g,1kg
Transportation: by courier/ by air/ by sea
Key words:
Related Products
Related Products
Inquiry